INmune Bio, Inc. (INMB)
1.445
+0.04
(+2.48%)
USD |
NASDAQ |
May 21, 16:00
1.445
0.00 (0.00%)
After-Hours: 16:25
INmune Bio Total Liabilities (Quarterly) : 6.194M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| PDS Biotechnology Corp. | 20.77M |
| Sangamo Therapeutics, Inc. | 78.92M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.82M |
| Shareholders Equity (Quarterly) | 19.62M |
| Debt to Equity Ratio | 0.0769 |
| Current Ratio | 4.236 |
| Net Debt Paydown Yield | -0.75% |